300357 Stock Overview
A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.93 |
| 52 Week High | CN¥30.61 |
| 52 Week Low | CN¥16.32 |
| Beta | 0.70 |
| 11 Month Change | 34.80% |
| 3 Month Change | 16.22% |
| 1 Year Change | -16.19% |
| 33 Year Change | -58.51% |
| 5 Year Change | -47.71% |
| Change since IPO | 307.78% |
Recent News & Updates
Recent updates
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.'s (SZSE:300357) P/E Is Still On The Mark Following 39% Share Price Bounce
Sep 30
These 4 Measures Indicate That Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Is Using Debt Reasonably Well
Sep 26Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Has Announced That Its Dividend Will Be Reduced To CN¥0.185
Jun 30Investor Optimism Abounds Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357) But Growth Is Lacking
May 27Calculating The Fair Value Of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357)
May 07Is Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) A Risky Investment?
Mar 22Shareholder Returns
| 300357 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.5% | 1.6% | 2.7% |
| 1Y | -16.2% | 0.7% | 4.6% |
Return vs Industry: 300357 underperformed the CN Pharmaceuticals industry which returned 0.7% over the past year.
Return vs Market: 300357 underperformed the CN Market which returned 4.6% over the past year.
Price Volatility
| 300357 volatility | |
|---|---|
| 300357 Average Weekly Movement | 11.1% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in CN Market | 11.4% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300357's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300357's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 1,709 | Gengxi Hu | www.wolwobiotech.com |
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a farinae farinae drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kits; and Changdian II, a house dust mite skin pricking diagnostic kits. It also involved in the research and development of stem cells and medical artificial intelligence solutions.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Fundamentals Summary
| 300357 fundamental statistics | |
|---|---|
| Market cap | CN¥12.01b |
| Earnings (TTM) | CN¥310.81m |
| Revenue (TTM) | CN¥891.15m |
38.6x
P/E Ratio13.5x
P/S RatioIs 300357 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300357 income statement (TTM) | |
|---|---|
| Revenue | CN¥891.15m |
| Cost of Revenue | CN¥42.40m |
| Gross Profit | CN¥848.76m |
| Other Expenses | CN¥537.94m |
| Earnings | CN¥310.81m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 24, 2024
| Earnings per share (EPS) | 0.59 |
| Gross Margin | 95.24% |
| Net Profit Margin | 34.88% |
| Debt/Equity Ratio | 1.9% |
How did 300357 perform over the long term?
See historical performance and comparison